跳至主要内容
临床试验/CTRI/2023/05/052604
CTRI/2023/05/052604已完成不适用

Comparison of oral Terbinafine Vs oral Itraconazole in patients of Tinea Cruris in a tertiary care hospital of North East India- an open level randomized clinical trial

AGMC GBP Hospital1 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2023年5月20日最近更新:

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
170
试验地点
1
主要终点
Erythema, Scaling, peripheral spread to other body sites

研究概览

简要总结

Positive KOH Tinea cruris patients will be randomized and  recruited into two groups and oral Terbinafine 500 mg and oral Itraconazole 100 mg will be given for 14 days. The purpose of the study is to compare the safety and efficiency of Terbinafine and Itraconazole. For that purpose LFT will be 0 and 42 days and KOH will be done at 0, 14 and 42 days of treatment.

研究设计

研究类型
Interventional
分配方式
Permuted block randomization, variable
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • ALL NEWLY DIAGNOSED TINEA CRURIS SUBJECTS HAVE NOT RECEIVED ANTIFUNGAL IN LAST 14 DAYS.

排除标准

  • PREGNANT AND LACTATING WOMEN PATIENTS ON IMMUNOSUPPRESSIVE DRUGS PATIENTS UNWILLING FOR A REGULAR FOLLOW UP PATIENTS WITH RELAPSE AND RECURRENT CASES OF TINEA CRURIS.

结局指标

主要结局

Erythema, Scaling, peripheral spread to other body sites

时间窗: After 14 days and 42 days of treatment

次要结局

  • LFT(42 DAYS)

研究者

发起方
AGMC GBP Hospital
申办方类型
Government medical college

研究点 (1)

Loading locations...

相似试验

Comparison of Terbinafine and Itraconazole in... | 临床试验